3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
4
Neuroblastoma
3
Medulloblastoma
2
Carcinoid Tumor
2
von Hippel-Lindau Disease
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Prostatic Neoplasms
1
Parathyroid Neoplasms
1
Paraganglioma
1
Multiple Endocrine Neoplasia
1
Hypoglycemia
1
Hyperparathyroidism
1
Hypercalcemia
1
Cancer Diagnosis
1
Interventions
Temozolomide
47
Bevacizumab
41
Radiotherapy
17
Magnetic Resonance Spectroscopy
14
Irinotecan
11
Nivolumab
8
Everolimus
7
Radiation
6
poly ICLC
5
X-Rays
5
Phantoms, Imaging
5
Carboplatin
5
pembrolizumab
4
fluorodopa F 18
4
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Erlotinib Hydrochloride
4
Carmustine
4
ribociclib
3
palbociclib
3
ivosidenib
3
antineoplaston A10
3
Vorinostat
3
Radiotherapy, Intensity-Modulated
3
Radiosurgery
3
Modafinil
3
Lomustine
3
Biopsy
3
veliparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Glioma
×
gallium Ga 68 dotatate
×
Clear all
No trials found.